Annovis Bio Inc

NYSE ANVS

Download Data

Annovis Bio Inc Average Collection Period 2 year CAGR for the quarter ending September 20, 2024

Annovis Bio Inc Average Collection Period 2 year CAGR is NA for the quarter ending September 20, 2024. The average collection period measures the average number of days it takes for a company to collect payments from its customers. It is calculated by dividing 365 by the ratio of revenue to the average of receivables and other current assets. A lower average collection period indicates a more efficient collection process and better cash flow management, while a higher period may suggest delayed payments and potential liquidity challenges. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
NYSE: ANVS

Annovis Bio Inc

CEO Dr. Maria L. Maccecchini Ph.D.
IPO Date Feb. 12, 2010
Location United States
Headquarters 1055 Westlakes Drive, Berwyn, PA, United States, 19312
Employees 6
Sector Healthcare
Industry Biotechnology
Description

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.

Similar companies

AVXL

Anavex Life Sciences Corp

NA

NA

ANIX

Anixa Biosciences Inc

NA

NA

ABOS

Acumen Pharmaceuticals Inc

NA

NA

DAWN

Day One Biopharmaceuticals Inc

NA

NA

CUE

Cue Biopharma

NA

NA

LTRN

Lantern Pharma Inc

NA

NA

GRCL

Gracell Biotechnologies Inc.

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email